Decrease of cyclic GMP in cerebellum by intrastriatal D-Ala2-Met-Enkephalinamide1
- 30 June 1978
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 23 (4) , 335-339
- https://doi.org/10.1016/0024-3205(78)90017-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Striatal lesions with kainic acid: neurochemical characteristicsBrain Research, 1977
- An Analog of Enkephalin Having Prolonged Opiate-Like Effects in VivoScience, 1977
- Regulation of cyclic GMP in cerebellum by a striatal dopaminergic mechanismNature, 1977
- Evidence on the cellular localization of adenyl cyclase in the neostriatumBrain Research, 1976
- [D-Ala 2 ]-Met-Enkephalinamide: A Potent, Long-Lasting Synthetic Pentapeptide AnalgesicScience, 1976
- Climbing fiber activation and 3′,5′-cyclic guanosine monophosphate (cGMP) content in cortex and deep nuclei of cerebellumBrain Research, 1976
- Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphologyNeuropharmacology, 1974
- Simultaneous isolation of adenosine 3′,5′-cyclic monophosphate (cAMP) and guanosine 3′,5′-cyclic monophosphate (cGMP) in small tissue samplesAnalytical Biochemistry, 1974
- Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamenNeuropharmacology, 1971